Literature DB >> 1987766

Urinary excretion of the C5b-9 membrane attack complex of complement is a marker of immune disease activity in autologous immune complex nephritis.

C J Pruchno1, M M Burns, M Schulze, R J Johnson, P J Baker, C E Alpers, W G Couser.   

Abstract

The urinary excretion of the C5b-9 membrane attack complex of complement correlates with glomerular deposition of antibody in the passive Heymann nephritis (PHN) model of membranous nephropathy (MN). To determine if this parameter can be correlated with antibody deposition in a model of MN induced by an autologous mechanism and thus more analogous to human MN, the relationship of urinary C5b-9 to ongoing glomerular immune complex formation late in autologous immune complex nephritis (AICN) was studied. Based on urinary C5b-9, the animals were divided into two groups at 12 weeks after induction of AICN, those with persistently high urinary C5b-9 excretion and those in whom urinary excretion of C5b-9 returned to undetectable levels. While all rats developed glomerular deposition of rat IgG and significant proteinuria, high C5b-9 excretors had greater proteinuria and prolonged positive staining for glomerular C3. When normal syngeneic kidneys were transplanted into rats (n = 3) from each group, only those with persistent C5b-9 excretion developed subepithelial immune deposits of rat IgG in the transplanted kidney. As in the PHN model of MN, proteinuria was dissociated widely from urinary C5b-9 excretion, glomerular C3 staining, and evidence of circulating antibody. Thus these findings demonstrate that urinary excretion of C5b-9 serves as an index of on-going immunologic disease activity in the AICN model of MN, while proteinuria does not.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1987766      PMCID: PMC1886046     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  32 in total

1.  Circulatory antigens of Heymann nephritis. I. Identification and partial characterization.

Authors:  A K Singh; S P Makker
Journal:  Immunology       Date:  1986-03       Impact factor: 7.397

2.  Autologous immune-complex pathogenesis of experimental allergic glomerulonephritis.

Authors:  T S Edgington; R J Glassock; F J Dixon
Journal:  Science       Date:  1967-03-17       Impact factor: 47.728

3.  Immune-complex glomerulopathy in patients treated with captopril.

Authors:  S J Hoorntje; C G Kallenberg; J J Weening; A J Donker; T H The; P J Hoedemaeker
Journal:  Lancet       Date:  1980-06-07       Impact factor: 79.321

4.  Complement-induced glomerular epithelial cell injury. Role of the membrane attack complex in rat membranous nephropathy.

Authors:  A V Cybulsky; H G Rennke; I D Feintzeig; D J Salant
Journal:  J Clin Invest       Date:  1986-04       Impact factor: 14.808

5.  Factors influencing susceptibility of LEW rats to Heymann nephritis.

Authors:  B Noble; J B Van Liew; G A Andres; J R Brentjens
Journal:  Clin Immunol Immunopathol       Date:  1984-02

6.  The natural history of renal function in untreated idiopathic membranous glomerulonephritis in adults.

Authors:  A M Davison; J S Cameron; D N Kerr; C S Ogg; R W Wilkinson
Journal:  Clin Nephrol       Date:  1984-08       Impact factor: 0.975

7.  Effect of reimmunization with Fx1A late in the course of Heymann nephritis.

Authors:  B Noble; J B Van Liew; J R Brentjens; G A Andres
Journal:  Lab Invest       Date:  1982-11       Impact factor: 5.662

8.  Production of nephrotic syndrome in rats by Freund's adjuvants and rat kidney suspensions.

Authors:  W HEYMANN; D B HACKEL; S HARWOOD; S G WILSON; J L HUNTER
Journal:  Proc Soc Exp Biol Med       Date:  1959-04

9.  Course of transplanted Heymann nephritis kidney in normal host. Implications for mechanism of proteinuria in membranous glomerulonephropathy.

Authors:  S P Makker; J J Kanalas
Journal:  J Immunol       Date:  1989-05-15       Impact factor: 5.422

10.  Increased urinary excretion of C5b-9 distinguishes passive Heymann nephritis in the rat.

Authors:  M Schulze; P J Baker; D T Perkinson; R J Johnson; R F Ochi; R A Stahl; W G Couser
Journal:  Kidney Int       Date:  1989-01       Impact factor: 10.612

View more
  6 in total

1.  Phospholipase A2 receptor autoantibodies and clinical outcome in patients with primary membranous nephropathy.

Authors:  Elion Hoxha; Ina Thiele; Gunther Zahner; Ulf Panzer; Sigrid Harendza; Rolf A K Stahl
Journal:  J Am Soc Nephrol       Date:  2014-03-07       Impact factor: 10.121

Review 2.  Membrane signaling by complement C5b-9, the membrane attack complex.

Authors:  A Nicholson-Weller; J A Halperin
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

3.  Clinical Use of Complement, Inflammation, and Fibrosis Biomarkers in Autoimmune Glomerulonephritis.

Authors:  Myriam Khalili; Arnaud Bonnefoy; Dominique S Genest; Jérémy Quadri; Jean-Philippe Rioux; Stéphan Troyanov
Journal:  Kidney Int Rep       Date:  2020-07-23

4.  Antibodies to glycolipids activate complement and promote proteinuria in passive Heymann nephritis.

Authors:  M Susani; M Schulze; M Exner; D Kerjaschki
Journal:  Am J Pathol       Date:  1994-04       Impact factor: 4.307

5.  Extensive complement activation in hereditary porcine membranoproliferative glomerulonephritis type II (porcine dense deposit disease).

Authors:  J H Jansen; K Høgåsen; T E Mollnes
Journal:  Am J Pathol       Date:  1993-11       Impact factor: 4.307

6.  Glomerular C3c localization indicates ongoing immune deposit formation and complement activation in experimental glomerulonephritis.

Authors:  M Schulze; C J Pruchno; M Burns; P J Baker; R J Johnson; W G Couser
Journal:  Am J Pathol       Date:  1993-01       Impact factor: 4.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.